Used in: Figure 1 from Kirman et al. (2012), Physiologically based pharmacokinetic model for rats and mice orally exposed to chromium; Figures 3 and S1 from Thompson et al. (2011), Application of the U.S. EPA Mode of Action Framework for Purposes of Guiding … Continue reading
Used in: Figures 4 and 5 from Thompson et al. (2012), Comparison of the Effects of Hexavalent Chromium in the Alimentary Canal of F344 Rats and B6C3F1 Mice Following Exposure in Drinking Water: Implications for Carcinogenic Modes of Action; Table 2 from Kirman et … Continue reading
Used in: Figures 4, 6, and Tables 1, 2 from Thompson et al. (2011), Application of the U.S. EPA Mode of Action Framework for Purposes of Guiding Future Research: A Case Study Involving the Oral Carcinogenicity of Hexavalent Chromium; Figures 1, 4, 5, … Continue reading
Used in: Figure 3 from Thompson et al. (2013), Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans; Figure 9 from Kopec et al. (2012), Genome-wide gene expression effects in … Continue reading